Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells
- PMID: 10450921
- DOI: 10.1023/a:1018959029186
Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells
Abstract
Purpose: To study peculiarities and the mechanism of the anticancer effect of free and HPMA copolymer-bound ADR in sensitive and resistant human ovarian carcinoma cells.
Methods: Sensitive A2780 and ADR resistant A2780/AD cells were exposed to different doses of drugs during 12, 24, 36, 48, 60, and 72 hours. Cell viability, drug accumulation, apoptosis, cellular metabolism, lipid peroxidation, DNA content and gene expression were studied.
Results: HPMA copolymer-bound ADR (P(GFLG)-ADR) possessed a comparable cytotoxicity to free ADR when comparison was based on intracellular concentrations. While free ADR up-regulated genes encoding ATP driven efflux pumps (MDR1, MRP), P(GFLG)-ADR overcame existing pumps and down regulated the MRP gene. Free ADR also activated cell metabolism and expression of genes responsible for detoxification and DNA repair. P(GFLG)-ADR down-regulated HSP-70, GST-pi, BUDP, Topo-IIalpha, beta, and TK-1 genes. Apoptosis, lipid peroxidation and DNA damage were significantly higher after exposure to P(GFLG)-ADR, as reflected by simultaneous activation of p53, c-fos in A2780 cells) or c-jun (A2780/AD) signaling pathways and inhibition of the bcl-2 gene. Differences between free ADR and P(GFLG)-ADR increased with the time of incubation and drug concentration.
Conclusions: P(GFLG)-ADR overcame drug efflux pumps, more significantly induced apoptosis and lipid peroxidation, inhibited DNA repair, replication, and biosynthesis when compared to free ADR.
Similar articles
-
Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma.Int J Cancer. 2000 Apr 1;86(1):108-17. doi: 10.1002/(sici)1097-0215(20000401)86:1<108::aid-ijc17>3.0.co;2-8. Int J Cancer. 2000. PMID: 10728603
-
HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line.Eur J Pharm Biopharm. 2000 Jan;49(1):11-5. doi: 10.1016/s0939-6411(99)00033-8. Eur J Pharm Biopharm. 2000. PMID: 10613922
-
HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line.J Control Release. 1998 Jul 31;54(2):223-33. doi: 10.1016/s0168-3659(98)00009-1. J Control Release. 1998. PMID: 9724909
-
Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line.J Control Release. 1999 May 20;59(2):133-48. doi: 10.1016/s0168-3659(98)00186-2. J Control Release. 1999. PMID: 10332049
-
HPMA copolymer delivery of chemotherapy and photodynamic therapy in ovarian cancer.Adv Exp Med Biol. 2003;519:101-23. doi: 10.1007/0-306-47932-X_7. Adv Exp Med Biol. 2003. PMID: 12675211 Review.
Cited by
-
Doxorubicin attached to HPMA copolymer via amide bond modifies the glycosylation pattern of EL4 cells.Tumour Biol. 2010 Aug;31(4):233-42. doi: 10.1007/s13277-010-0019-7. Epub 2010 Feb 24. Tumour Biol. 2010. PMID: 20556593
-
HPMA copolymer-bound doxorubicin induces apoptosis in ovarian carcinoma cells by the disruption of mitochondrial function.Mol Pharm. 2006 May-Jun;3(3):351-61. doi: 10.1021/mp050065e. Mol Pharm. 2006. PMID: 16749867 Free PMC article.
-
Protease-activated drug development.Theranostics. 2012;2(2):156-78. doi: 10.7150/thno.4068. Epub 2012 Feb 8. Theranostics. 2012. PMID: 22400063 Free PMC article.
-
Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin.Pharm Res. 2003 Mar;20(3):351-9. doi: 10.1023/a:1022687617318. Pharm Res. 2003. PMID: 12669953
-
Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells.Small. 2009 Dec;5(23):2673-7. doi: 10.1002/smll.200900621. Small. 2009. PMID: 19780069 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous